Coyle PK. Disease-modifying agents in multiple sclerosis. Ann Indian Acad Neurol. 2009 Oct–Dec; 12(4): 273–282.
Gasperini C, Ruggieri S, Pozzilli C. Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets. Therapeutics and Clinical Risk Management 2010; (6): 391–399
Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, on behalf of the Fampridine MS-F203 Investigators. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet 2009; 373 (9665): 732-8.
Calabresi PA. Diagnosis and Management of Multiple Sclerosis. Am Fam Physician. 2004 Nov 15;70(10):1935-1944.
Harrison’s Principles of Internal Medicine 17th Edition.
Author: Dr. Simi Paknikar
Editor: Dr. Sunil Shroff
Technically Checked by: Lingaraj
Published on Apr 10, 2013
Last Updated on Jun 22, 2018
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Dr. Simi Paknikar. (2018, June 22). Reference – Multiple Sclerosis. Medindia. Retrieved on Apr 19, 2024 from https://www.medindia.net/health/treatment/multiple-sclerosis-treatment-course-modification-reference.htm.
MLA
Dr. Simi Paknikar. "Reference – Multiple Sclerosis". Medindia. Apr 19, 2024. <https://www.medindia.net/health/treatment/multiple-sclerosis-treatment-course-modification-reference.htm>.
Chicago
Dr. Simi Paknikar. "Reference – Multiple Sclerosis". Medindia. https://www.medindia.net/health/treatment/multiple-sclerosis-treatment-course-modification-reference.htm. (accessed Apr 19, 2024).
Harvard
Dr. Simi Paknikar. 2018. Reference – Multiple Sclerosis. Medindia, viewed Apr 19, 2024, https://www.medindia.net/health/treatment/multiple-sclerosis-treatment-course-modification-reference.htm.
